De Jong, Hilda J.I.Price, DavidVoorham, JacoScadding, Glenis KBachert, ClausCanonica, Giorgio WalterSmith, PeterWahn, UlrichRyan, DermotCastillo, Jose A.Carter, Victoria AMurray, Ruth BPrice, David B2021-01-062021-01-062020-12De Jong, H J I, Price, D, Voorham, J, Scadding, G K, Bachert, C, Canonica, G W, Smith, P, Wahn, U, Ryan, D, Castillo, J A, Carter, V A, Murray, R B & Price, D B 2020, 'Evaluating the Real-life Effect of MP-AzeFlu On Asthma Outcomes In Patients With Allergic Rhinitis and Asthma In UK Primary Care', World Allergy Organization Journal, vol. 13, no. 12, 100490. https://doi.org/10.1016/j.waojou.2020.1004901939-4551https://hdl.handle.net/2164/15588This study was supported by funding from BGP Products Operations GmbH (A MylanCompany). BGP Products Operations GmbH was given the opportunity to review the manuscript for medical and scientific accuracy as well as for intellectual property considerations. The dataset supporting the conclusions of this article was derived from the Optimum Patient Care Research Database (www.opcrd.co.uk). The OPCRD has ethical approval from the National Health Service (NHS) Research Authority to hold and process anonymized research data (Research Ethics Committee reference: 15/EM/0150). This study was approved by the Anonymized Data Ethics Protocols and Transparency (ADEPT) committee – the independent scientific advisory committee for the OPCRD. The authors do not have permission to give public access to the study dataset; researchers may request access to OPCRD data for their own purposes. Access to OCPRD can be made via the OCPRD website (https://opcrd.co.uk/our-database/data-requests/) or via the enquiries email info@opcrd.co.uk.18992227engcontrolexacerbationsrescue medicationR MedicineSupplementary DataRJournal article10.1016/j.waojou.2020.1004901312